Karachi: Dow University of Health Sciences (DUHS) medical experts have claimed on Monday that they have created a drug to treat patients suffering from the coronavirus disease.
According to the details, DUHS medical experts claim that intravenous immunoglobulin (IVIG) can cure COVID-19 patients.
Professor Muhammad Saeed Qureshi, a research team member, said that intravenous immunoglobulin is a huge step forward in combating new coronaviruses.
He said that globulin is produced using purified antibodies obtained from recovered coronavirus patients. Professor Shaukat Ali, head of the research team, said that in a pandemic crisis, corona therapy is a silver lining.
On April 09, the Drug Regulatory Authority of Pakistan (DRAP) allowed clinical trials of blood plasma therapy to treat coronavirus patients in the country.
Plasma is a fluid in the blood that is full of post-disease antibodies. It has been proven to be effective in treating infectious diseases such as Ebola and SARS in small-scale studies.
Dr. Zafar Mirza, Special Assistant to the Minister of Health, announced the news here today. “DRAP has also approved the local production of antimalarial chloroquine raw materials.”
According to the National Information Homepage, as of April 13, there have been 5,374 confirmed coronavirus cases in the country, and 93 people have died of infection so far.
According to available statistics, the country has reported 336 cases in the past 24 hours.
Punjab has the highest infection rate of 2594 cases, Sind province 1411 cases, Khyber Pakhtunkhwa (KP) 744 cases, Bal Luchi province 230 cases, Gilgit-Balstanstan (GB) There were 224 cases, 131 cases in Islamabad, and 40 cases in Azadja Jam and Kashmir.